Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers October 20, 2018
Pharmacy Choice - News - U.S. Pharmaceutical Industry - October 20, 2018

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

10/19/18 - Abbott's HeartMate 3 Heart Pump Now FDA Approved for Advanced Heart Failure Patients Not Eligible for a Heart Transplant
ABBOTT PARK, Ill., Oct. 19, 2018/ PRNewswire/ Abbott announced today that the HeartMate 3? Left Ventricular Assist Device has received U.S. Food and Drug Administration approval as a destination therapy for people living with advanced heart failure. "Approximately a quarter of a million people are living with advanced heart failure, and many o
10/19/18 - AbbVie and Morphic Therapeutic Announce Collaboration Targeting Fibrotic Diseases
NORTH CHICAGO- AbbVie, a research-based global biopharmaceutical company, and Morphic Therapeutic, a biotechnology company developing oral integrin therapies, announced today that the companies have entered into a research and development collaboration designed to advance a number of Morphic's oral integrin therapeutics for fibrosis-related...
10/19/18 - Abeona Therapeutics Appoints Joao Siffert, M.D. Head of Research and Development and Chief Medical Officer
NEW YORK and CLEVELAND- Abeona Therapeutics Inc., a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the appointment of Joao Siffert, M.D. as Head of Research and Development and Chief Medical Officer. Both Dr. Siffert and Ms. Patil repor
10/19/18 - AcelRx Provides Updated Comments Following Positive FDA Advisory Committee Meeting
In response to opinions expressed following the U.S. Food and Drug Administration Anesthetic and Analgesic Drug Products Advisory Committee meeting on October 12, AcelRx Pharmaceuticals, Inc. stands by the safety, efficacy and medical need for its investigational therapy, DSUVIA?. Developed in collaboration with the Department of Defense, DSUVI
10/19/18 - AIT Therapeutics Presented Its High-Dose Nitric Oxide In Vitro Data at the North American Cystic Fibrosis Conference [T-break Tech (Middle East)]
-AIT Therapeutics, Inc., a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, today presented a poster with data on high-dose in vitro inhaled NO at the North American Cystic...
10/19/18 - Akorn Appeals Fresenius Kabi Ruling
LAKE FOREST- Akorn, Inc., a leading specialty generic pharmaceutical company, today announced that the company filed a notice of appeal to the Supreme Court of the State of Delaware from the recent decision of the Delaware Court of Chancery rejecting Akorn's claims. Akorn, Inc. is a specialty generic pharmaceutical company engaged in the developmen
10/19/18 - Allena Pharmaceuticals Highlights Ongoing Efforts to Address Rare and Severe Metabolic Disorders Affecting the Kidney with Presentations at Upcoming Medical Meetings
NEWTON- Allena Pharmaceuticals, Inc., a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced presentations at two upcoming medical meetings. At the 2018 American College of Rheumatology Annual.
10/19/18 - Allergan to Showcase Continued Eye Care Innovation with New Data on Investigational Medicines at the American Academy of Ophthalmology Annual Meeting
Allergan plc, a leading global pharmaceutical company with a nearly 70- year heritage in ophthalmology, will present new data at the Annual Meeting of the American College of Ophthalmology to be held in Chicago, Illinois. "The data demonstrate our continued dedication to research and innovation aimed at finding new solutions to a cross-section o
10/19/18 - Almirall LLC Launches New Name at Fall Clinical Dermatology Congress
Almirall, LLC, formerly Aqua Pharmaceuticals, a U.S. leader in skin health medical solutions, used the start of the Fall Clinical Dermatology Congress to officially launch their new name. Almirall, LLC is part of the larger Almirall, S.A. family, an internationally-recognized global dermatology pharmaceutical company, with a strong focus on skin
10/19/18 - Amneal Announces Approval of Carmustine for Injection USP, 100 mg/vial - Preparing for Launch
Amneal Pharmaceuticals, Inc., today announced that it has received FDA approval for a generic version of BiCNU for injection, 100 mg. About Amneal Amneal Pharmaceuticals, Inc., headquartered in Bridgewater, NJ, is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar
10/19/18 - Amneal Announces the Approval and Launch of Generic Isoproterenol Hydrochloride Injection USP
Amneal Pharmaceuticals, Inc., today announced that it has received FDA approval for a generic version of Isuprel TM Injection USP, 0.2 mg/mL and 1 mg/5 mL Single-Dose Vials. About Amneal Amneal Pharmaceuticals, Inc., headquartered in Bridgewater, NJ, is an integrated specialty pharmaceutical company focused on developing, manufacturing and distri
10/19/18 - Anavex Life Sciences Announces FDA Approval of IND for Phase 2 Trial of ANAVEX2-73 in Patients with Rett Syndrome
Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer s disease, Rett syndrome and other central nervous system diseases, today announced that the Company has received confirmation from the U.S. Foo
10/19/18 - Anavex Life Sciences Corp (NASDAQ:AVXL) price target set to $7.00 by Maxim Group
Analyst Ratings For Anavex Life Sciences Corp (NASDAQ:AVXL) Today, Maxim Group set its price target on Anavex Life Sciences Corp (NASDAQ:AVXL) to $7.00 per share. There are 4 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock. The current consensus rating on Anavex Life Sciences Corp (NASDAQ:AVXL) is Buy [?] The pos
10/19/18 - Apocarotenal Market: Rising Demand for Nature-Identical Colors in the Food and Beverages Industry to Bolster Industry Growth-TMR: Apocarotenal Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2026
Albany, NY 10/19/2018 Apocarotenal belongs to the group of plant substances called the carotenoid. The presence of Apocarotenal is usually seen in the citrus fruits and spinach. The main usage of Apocarotenal is in the coloring of food, beverages, cosmetics, and pharmaceutical industry.
10/19/18 - BERG to Present New Data Describing Details on Progress of its Oncology Portfolio and Precision Medicine Applications at the European Society for Medical Oncology 2018 Congress
BERG LLC, a Boston- based biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the presentation of three posters on the progression of its oncology and artificial intelligence/ Biomarker portfolio at the European Society of Medical Oncology 2018 Annual Congress being held October 19-23, 2018
10/19/18 - Bevacizumab Biosimilar Market Clinical Area Growth Segmentation 2018 to 2025
Harrisburg, NC 10/19/2018 Marketinsightsreports provides "Global Bevacizumab Biosimilar Market Insights, Forecast To 2025" which includes the estimation of market size for value and volume. Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bevacizumab Biosimilar Market, to estimate the size of v
10/19/18 - BeyondSpring to Host Second-Quarter 2018 Financial Results and Operational Update Conference Call on October 23, 2018
BeyondSpring Inc., a global, clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that the Company will report second-quarter 2018 financial results and host an operational and clinical update conference call on Tuesday, October 23, 2018, at 8:00 a.m. Eastern Time. About BeyondSpring.
10/19/18 - BioCorRx Strengthens Intellectual Property Portfolio with Acquisition of Several Patent/Patent Pending Families
via NEWMEDIAWIRE BioCorRx Inc., a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that the Company s R&D subsidiary, BioCorRx Pharmaceuticals, has acquired a portfolio of six Therakine Biodelivery GmbH patent families that broadly cover sustained release delivery platforms for t
10/19/18 - BioLineRx Presents Top-Line Results from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress
BL-8040 in combination with KEYTRUDA demonstrated encouraging disease control and overall survival in patients with metastatic pancreatic cancer. Tel Aviv, Israel- BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced top-line results from the dual combination arm of the Phase 2 a...
10/19/18 - Calamus Root Market: Emerging Demand Among the Consumers and Product Developers to Benifits the Industry Growth -TMR: Calamus Root Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2026
Albany, NY 10/19/2018 Calamus root is rich in vitamin C, hence taken as a dietary vitamin supplement on the regular basis to nourish the replicating cells. Since calamus root supplement is obtained from a natural source, consumers show more towards it. Due to the presence of anti-oxidant nutrients, calamus root is highly utilized in nutraceut
10/19/18 - Can-Fite CEO to present as Expert Speaker on Namodenoson at NASH Summit Europe 2018
PETACH TIKVA- Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address liver and inflammatory diseases, today announced that its CEO, Dr. Can-Fite's is currently enrolling patients for a Phase II NAFLD/NASH study in three Israeli sites, including Hadassah Medical Center, Jerusalem, and t
10/19/18 - Cancer Supportive Care Drugs Market Worth $23.5 Billion By 2022: Grand View Research, Inc.
According to report by Grand View Research, Inc. The global cancer supportive care drugs market size is expected to be valued at USD 23.5 billion by 2022. The market to be driven by large number of side-effects associated with cancer treatment, increasing uptake of biosimilars, and availability of effective treatment methods, including target speci
10/19/18 - Canon Medical Showcases FDA-Cleared Aquilion Precision at ASTRO 2018
At this year s American Society of Radiation Oncology annual meeting in San Antonio, Texas, October 21-24, 2018, Canon Medical Systems USA, Inc. will showcase its recently FDA- cleared Aquilion Precision TM, the world s first Ultra-High Resolution CT system. The Aquilion Precision sets a new bar for CT imaging, said Dominic Smith, senio
10/19/18 - Castle Creek Pharma Announces $71.8 Million in New Investment to Expand Research for Rare Dermatologic Conditions
Castle Creek plans to use this additional funding to support the late-stage development of an investigational drug, diacerein ointment. "We are focused on developing CCP-020 as an important treatment for EBS and look forward to targeting the new investment from Fidelity and Valor towards the late-stage development of this investigational drug," sa
10/19/18 - ChemioCare Expands Proprietary Transdermal Platform
ChemioCare USA Inc., a biotech company focused on transforming patient outcomes in cancer supportive care, today announces a successful Drug Enforcement Administration registration: ChemioCare s exclusive formulation development partner, Transdermal Research Pharm Laboratories LLC, has obtained a new registration with the DEA as a Manufacturer
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement